» Articles » PMID: 38974119

Evaluation of a Covalent Library of Diverse Warheads (CovLib) Binding to JNK3, USP7, or P53

Overview
Specialty Pharmacology
Date 2024 Jul 8
PMID 38974119
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Over the last few years, covalent fragment-based drug discovery has gained significant importance. Thus, striving for more warhead diversity, we conceived a library consisting of 20 covalently reacting compounds. Our covalent fragment library (CovLib) contains four different warhead classes, including five α-cyanoacacrylamides/acrylates (CA), three epoxides (EO), four vinyl sulfones (VS), and eight electron-deficient heteroarenes with a leaving group (SAr/SN).

Methods: After predicting the theoretical solubility of the fragments by LogP and LogS during the selection process, we determined their experimental solubility using a turbidimetric solubility assay. The reactivities of the different compounds were measured in a high-throughput 5,5'-dithiobis-(2-nitrobenzoic acid) DTNB assay, followed by a (glutathione) GSH stability assay. We employed the CovLib in a (differential scanning fluorimetry) DSF-based screening against different targets: c-Jun N-terminal kinase 3 (JNK3), ubiquitin-specific protease 7 (USP7), and the tumor suppressor p53. Finally, the covalent binding was confirmed by intact protein mass spectrometry (MS).

Results: In general, the purchased fragments turned out to be sufficiently soluble. Additionally, they covered a broad spectrum of reactivity. All investigated α-cyanoacrylamides/acrylates and all structurally confirmed epoxides turned out to be less reactive compounds, possibly due to steric hindrance and reversibility (for α-cyanoacrylamides/acrylates). The SAr and vinyl sulfone fragments are either highly reactive or stable. DSF measurements with the different targets JNK3, USP7, and p53 identified reactive fragment hits causing a shift in the melting temperatures of the proteins. MS confirmed the covalent binding mode of all these fragments to USP7 and p53, while additionally identifying the SAr-type electrophile SN002 as a mildly reactive covalent hit for p53.

Conclusion: The screening and target evaluation of the CovLib revealed first interesting hits. The highly cysteine-reactive fragments VS004, SN001, SN006, and SN007 covalently modify several target proteins and showed distinct shifts in the melting temperatures up to +5.1 °C and -9.1 °C.

Citing Articles

Covalent Fragments Acting as Tyrosine Mimics for Mutant p53-Y220C Rescue by Nucleophilic Aromatic Substitution.

Klett T, Stahlecker J, Jaag S, Masberg B, Knappe C, Lammerhofer M ACS Pharmacol Transl Sci. 2024; 7(12):3984-3999.

PMID: 39698266 PMC: 11651176. DOI: 10.1021/acsptsci.4c00414.

References
1.
Turnbull A, Ioannidis S, Krajewski W, Pinto-Fernandez A, Heride C, Martin A . Molecular basis of USP7 inhibition by selective small-molecule inhibitors. Nature. 2017; 550(7677):481-486. PMC: 6029662. DOI: 10.1038/nature24451. View

2.
Jorgensen W, Duffy E . Prediction of drug solubility from structure. Adv Drug Deliv Rev. 2002; 54(3):355-66. DOI: 10.1016/s0169-409x(02)00008-x. View

3.
Proj M, Knez D, Sosic I, Gobec S . Redox active or thiol reactive? Optimization of rapid screens to identify less evident nuisance compounds. Drug Discov Today. 2022; 27(6):1733-1742. DOI: 10.1016/j.drudis.2022.03.008. View

4.
McAulay K, Bilsland A, Bon M . Reactivity of Covalent Fragments and Their Role in Fragment Based Drug Discovery. Pharmaceuticals (Basel). 2022; 15(11). PMC: 9694498. DOI: 10.3390/ph15111366. View

5.
Hu M, Li P, Li M, Li W, Yao T, Wu J . Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell. 2003; 111(7):1041-54. DOI: 10.1016/s0092-8674(02)01199-6. View